Uncategorized
New glaucoma medications relax trabecular meshwork, lower episcleral venous pressure
CHICAGO – IOP lowering through three different mechanisms comes together in one agent regardless of IOP baseline, a speaker said here at an Aerie Pharmaceuticals press briefing.Rhopressa relaxes the trabecular meshwork and increases outflow by inhibiting Rho kinase, lowers episcleral venous pressure, and reduces fluid production through inhibition of the norepinephrine transporter, Casey Kopczynski, PhD, said.